Nicoloff George, Blazhev Alexander, Petrova Chaika, Christova Petkama, Jordanova-Laleva Pavlima, Dekov Dancho, Dorovski Plamen
Departments of Biology and Pathological Physiology, University School of Medicine, Pleven, Bulgaria.
J Investig Med. 2005 Apr;53(3):128-34. doi: 10.2310/6650.2005.00308.
Antibodies to elastin breakdown products are found in the serum of all human subjects and correlate with their respective serum peptide levels. The presence of these antielastin antibodies (AEAbs) and the corresponding antigens in circulation leads to the formation of circulating immune complexes (CICs). The aim of this study was to determine if the serum levels of free AEAbs (not bound in CICs) correlate with the development of vascular complications in diabetic children. To this end, we used a method for detecting immune complexes (complement inhibition factor [CIF]-enzyme-linked immunosorbent assay [ELISA]) in combination with an ELISA for detection of AEAbs. The levels of free immunoglobulin G (IgG) AEAbs were studied in the sera of 54 diabetic children (mean age 12.3+/-4 years; diabetes duration 5.2+/-3.7 years). Thirty-two of the children had vascular complications (group 1), and 22 were without vascular complications (group 2). Twenty healthy children (mean age 13.6+/-4.2 years) were used as controls. The diabetics showed statistically significant higher levels of free AEAbs (0.490 E492+/-0.244 E492 vs 0.307 E492+/-0.081 E492; p = .02) compared with the control group. In group 1, free AEAbs showed statistically significant higher levels than controls (0.523+/-0.269 vs 0.307+/-0.081; p = .016). Eighteen of 54 (33%) patients were positive for free AEAbs (13 of 32 [41%] in group 1 and 5 of 22 [22%] in group 2). Free AEAb levels in all diabetics showed a correlation with systolic blood pressure (r = .44; p = .01), diastolic blood pressure (r = .46; p = .009), total cholesterol (r = .33; p = .05), triglycerides (r= .38; p = .03), high-density lipoprotein (r= -.46; p = .009), serum fructose (r= .43; p = .001), and microalbuminuria (r= .41; p = .002). Patients who had vascular pathology showed a correlation of free AEAbs with microalbuminuria (r= .434; p= .026), serum fructose (r= .63; p = .0004), hemoglobin A1c (r= .392; p = .043), and triglycerides (r= .456; p = .025). These findings suggest that elevated levels of free IgG AEAbs are associated with the development of diabetic vascular complications in children.
在所有人类受试者的血清中均能检测到抗弹性蛋白降解产物的抗体,且这些抗体与各自的血清肽水平相关。循环中这些抗弹性蛋白抗体(AEAbs)及其相应抗原的存在会导致循环免疫复合物(CICs)的形成。本研究的目的是确定游离AEAbs(未结合在CICs中的)血清水平是否与糖尿病儿童血管并发症的发生相关。为此,我们采用了一种检测免疫复合物的方法(补体抑制因子[CIF] - 酶联免疫吸附测定[ELISA])并结合用于检测AEAbs的ELISA。我们研究了54名糖尿病儿童(平均年龄12.3±4岁;糖尿病病程5.2±3.7年)血清中游离免疫球蛋白G(IgG)AEAbs的水平。其中32名儿童患有血管并发症(第1组),22名无血管并发症(第2组)。选取20名健康儿童(平均年龄13.6±4.2岁)作为对照。与对照组相比,糖尿病患者游离AEAbs水平在统计学上显著更高(0.490 E492±0.244 E492 vs 0.307 E492±0.081 E492;p = 0.02)。在第1组中,游离AEAbs水平在统计学上显著高于对照组(0.523±0.269 vs 0.307±0.081;p = 0.